Let's Get to Work

We envision a future where open data and global collaborations power the end of Alzheimer's disease and related dementias.

Watch Our Video

Supporting the Research Community with AD Connect and the AD Workbench

Two years ago this month, ADDI set out to support the research community in accelerating new discoveries in Alzheimer’s disease and related dementias.

Read more from Tetsuyuki Maruyama, ADDI’s Executive Director, about how AD Connect, our online community, and the AD Workbench, our data sharing and analysis platform are helping foster global collaboration and breaking down data silos.

Read More


Container image

AD Workbench

Our global, cloud-based platform allows you to share and discover data to accelerate discoveries and innovations.  Learn how the AD Workbench can advance your research.

Learn More
Container image

AD Connect

Our new online community allows you to engage with your fellow researchers – to ask for support, share ideas, and find resources. Learn how AD Connect can support your work.

Learn More
Container image

Stay in Touch

Receive our quarterly newsletter and latest announcements.

By checking this box, your form data will be used on other forms on the site for your convenience.




Our Partners

To accelerate the development of new and more effective treatments for AD, ADDI's partners are working better together to build better tools to help the brightest minds around the world access, use, and share dementia-related data.
               

      Dementias Platform      

           



About ADDI

The Alzheimer's Disease Data Initiative (ADDI) is on a mission to fundamentally transform Alzheimer's disease (AD) research.  Through a free data sharing platform, data science tools, funding opportunities, and global collaborations, ADDI is advancing scientific breakthroughs and accelerating progress towards new treatments and cures for AD and related dementias.

Read more about ADDI
Gates  Notes
Posted November 17, 2020
Quote Mark

I’m optimistic that this will make a real difference in Alzheimer’s research, because there are many examples where we’ve made progress on diseases after bringing together large amounts of data.